Market Cap 10.10M
Revenue (ttm) 513.02M
Net Income (ttm) -68.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.38%
Debt to Equity Ratio 3.78
Volume 1,270,768
Avg Vol 722,060
Day's Range N/A - N/A
Shares Out 34.40M
Stochastic %K 4%
Beta 3.82
Analysts Strong Sell
Price Target $3.00

Company Profile

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research cen...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 765 463 4527
Address:
2701 Kent Avenue, West Lafayette, United States
Sam201
Sam201 May. 13 at 5:08 PM
$NOTV 😂! Laughing or crying. 😭 you will soon!
0 · Reply
RocketThief
RocketThief May. 13 at 5:05 PM
$NOTV oh I’m still laughing, pumper 🤡. Both at this stock and at your shameful attempts to get others to bail you out
0 · Reply
Sam201
Sam201 May. 13 at 5:03 PM
$NOTV he was laughing yesterday 🤣😂
0 · Reply
RocketThief
RocketThief May. 13 at 4:47 PM
$NOTV you forgot to mention that this scandal-ridden company is almost completely out of cash and has over $410M of current debt.
0 · Reply
marvessa
marvessa May. 13 at 3:24 PM
$NOTV looks interesting
0 · Reply
BullyingIsGood
BullyingIsGood May. 13 at 3:11 PM
$NOTV I am in for a couple shares see how the ride is...
1 · Reply
LiveCommander
LiveCommander May. 13 at 3:03 PM
Fun stock i just discovered No buy or sell suggestion but just something i have not seen before. $NOTV $0.25 a share Market cap: $9M $500M in revenue 😳 Expecting $1B in revenue in 2030. Analysis price target: $1.50 (500% up) Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Just never seen this before @LiveCommander $PLTR $WEN $WOLF
0 · Reply
PhotonicDigger
PhotonicDigger May. 13 at 3:01 PM
$NOTV feels a bit “off narrative” Around $0.25 per share with a ~$9M market cap, yet revenue sits at a completely different scale. It operates in nonclinical drug development and testing — an under-the-radar but essential part of the pharma R&D chain. What stands out is the gap between how the market is pricing it and its actual operational footprint. So the question is: is this simply overlooked… or is the market pricing it that way for a reason? Free sharing and subscription 👉@PhotonicDigger.
0 · Reply
Sam201
Sam201 May. 13 at 2:39 PM
$NOTV loaded 30k more to 280k shares!
0 · Reply
Sam201
Sam201 May. 13 at 2:26 PM
$MGRX $NOTV this George excited every time this dips 10% 🤣😂.
0 · Reply
Latest News on NOTV
Inotiv provides notice regarding cybersecurity incident

2026-02-13T21:35:18.000Z - 3 months ago

Inotiv provides notice regarding cybersecurity incident


Inotiv Provides Notice Regarding Cybersecurity Incident

Feb 13, 2026, 4:30 PM EST - 3 months ago

Inotiv Provides Notice Regarding Cybersecurity Incident


Inotiv price target lowered to $1.50 from $3 at Lake Street

2026-02-10T13:46:26.000Z - 3 months ago

Inotiv price target lowered to $1.50 from $3 at Lake Street


Inotiv Earnings Call Transcript: Q1 2026

Feb 9, 2026, 8:30 AM EST - 3 months ago

Inotiv Earnings Call Transcript: Q1 2026


Inotiv reports Q1 EPS (83c) vs. ($1.02) last year

2026-02-09T12:05:07.000Z - 3 months ago

Inotiv reports Q1 EPS (83c) vs. ($1.02) last year


Inotiv partners with Vugene to advance AI-driven drug discovery

2025-12-11T14:05:20.000Z - 5 months ago

Inotiv partners with Vugene to advance AI-driven drug discovery


Inotiv price target lowered to $3 from $5 at Lake Street

2025-12-04T13:50:53.000Z - 5 months ago

Inotiv price target lowered to $3 from $5 at Lake Street


Inotiv Earnings Call Transcript: Q4 2025

Dec 3, 2025, 4:30 PM EST - 5 months ago

Inotiv Earnings Call Transcript: Q4 2025


Inotiv Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 11:00 AM EST - 6 months ago

Inotiv Transcript: Jefferies London Healthcare Conference 2025


Inotiv sees Q4 revenue $137.5M-$138.5M, consensus $133.35M

2025-11-17T21:20:48.000Z - 6 months ago

Inotiv sees Q4 revenue $137.5M-$138.5M, consensus $133.35M


Inotiv sees FY25 revenue $512.5M-$513.5M, consensus $508.25M

2025-11-17T21:20:30.000Z - 6 months ago

Inotiv sees FY25 revenue $512.5M-$513.5M, consensus $508.25M


Inotiv Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 12:50 PM EDT - 8 months ago

Inotiv Transcript: Baird Global Healthcare Conference 2025


Inotiv files $350M mixed securities shelf

2025-08-29T21:15:19.000Z - 9 months ago

Inotiv files $350M mixed securities shelf


Inotiv announces cybersecurity incident

2025-08-18T20:30:20.000Z - 9 months ago

Inotiv announces cybersecurity incident


Inotiv announces cybersecurity incident

2025-08-18T20:25:15.000Z - 9 months ago

Inotiv announces cybersecurity incident


Inotiv Earnings Call Transcript: Q3 2025

Aug 6, 2025, 4:30 PM EDT - 9 months ago

Inotiv Earnings Call Transcript: Q3 2025


Inotiv price target lowered to $5 from $6 at Lake Street

2025-05-08T13:25:01.000Z - 1 year ago

Inotiv price target lowered to $5 from $6 at Lake Street


Inotiv Earnings Call Transcript: Q2 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Inotiv Earnings Call Transcript: Q2 2025


Inotiv price target lowered to $9 from $10 at Craig-Hallum

2025-02-06T13:41:29.000Z - 1 year ago

Inotiv price target lowered to $9 from $10 at Craig-Hallum


Inotiv reports Q1 EPS ($1.02), consensus (42c)

2025-02-05T21:40:57.000Z - 1 year ago

Inotiv reports Q1 EPS ($1.02), consensus (42c)


Inotiv Earnings Call Transcript: Q1 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Inotiv Earnings Call Transcript: Q1 2025


Inotiv Earnings Call Transcript: Q4 2024

Dec 3, 2024, 4:30 PM EST - 1 year ago

Inotiv Earnings Call Transcript: Q4 2024


Inotiv Earnings Call Transcript: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Inotiv Earnings Call Transcript: Q3 2024


Inotiv, Inc. Provides Business Updates

Jun 10, 2024, 7:30 AM EDT - 2 years ago

Inotiv, Inc. Provides Business Updates


Inotiv Transcript: Jefferies Global Healthcare Conference

Jun 6, 2024, 10:30 AM EDT - 2 years ago

Inotiv Transcript: Jefferies Global Healthcare Conference


Inotiv Earnings Call Transcript: Q2 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Inotiv Earnings Call Transcript: Q2 2024


Inotiv Earnings Call Transcript: Q1 2024

Feb 7, 2024, 4:30 PM EST - 2 years ago

Inotiv Earnings Call Transcript: Q1 2024


Inotiv Earnings Call Transcript: Q4 2023

Dec 11, 2023, 4:30 PM EST - 2 years ago

Inotiv Earnings Call Transcript: Q4 2023


Inotiv, Inc. to Participate in Upcoming Investor Conferences

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Inotiv, Inc. to Participate in Upcoming Investor Conferences


Inotiv, Inc. Announces Changes to its Board Composition

Oct 16, 2023, 8:00 AM EDT - 2 years ago

Inotiv, Inc. Announces Changes to its Board Composition


Sam201
Sam201 May. 13 at 5:08 PM
$NOTV 😂! Laughing or crying. 😭 you will soon!
0 · Reply
RocketThief
RocketThief May. 13 at 5:05 PM
$NOTV oh I’m still laughing, pumper 🤡. Both at this stock and at your shameful attempts to get others to bail you out
0 · Reply
Sam201
Sam201 May. 13 at 5:03 PM
$NOTV he was laughing yesterday 🤣😂
0 · Reply
RocketThief
RocketThief May. 13 at 4:47 PM
$NOTV you forgot to mention that this scandal-ridden company is almost completely out of cash and has over $410M of current debt.
0 · Reply
marvessa
marvessa May. 13 at 3:24 PM
$NOTV looks interesting
0 · Reply
BullyingIsGood
BullyingIsGood May. 13 at 3:11 PM
$NOTV I am in for a couple shares see how the ride is...
1 · Reply
LiveCommander
LiveCommander May. 13 at 3:03 PM
Fun stock i just discovered No buy or sell suggestion but just something i have not seen before. $NOTV $0.25 a share Market cap: $9M $500M in revenue 😳 Expecting $1B in revenue in 2030. Analysis price target: $1.50 (500% up) Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Just never seen this before @LiveCommander $PLTR $WEN $WOLF
0 · Reply
PhotonicDigger
PhotonicDigger May. 13 at 3:01 PM
$NOTV feels a bit “off narrative” Around $0.25 per share with a ~$9M market cap, yet revenue sits at a completely different scale. It operates in nonclinical drug development and testing — an under-the-radar but essential part of the pharma R&D chain. What stands out is the gap between how the market is pricing it and its actual operational footprint. So the question is: is this simply overlooked… or is the market pricing it that way for a reason? Free sharing and subscription 👉@PhotonicDigger.
0 · Reply
Sam201
Sam201 May. 13 at 2:39 PM
$NOTV loaded 30k more to 280k shares!
0 · Reply
Sam201
Sam201 May. 13 at 2:26 PM
$MGRX $NOTV this George excited every time this dips 10% 🤣😂.
0 · Reply
bundy3333
bundy3333 May. 13 at 12:45 PM
$MGRX User jirishman $NOTV
0 · Reply
bundy3333
bundy3333 May. 13 at 12:43 PM
$MGRX User Sam201 $NOTV
0 · Reply
bundy3333
bundy3333 May. 13 at 12:42 PM
$NOTV User: Sam201 $MGRX
0 · Reply
RocketThief
RocketThief May. 12 at 5:26 PM
$NOTV LOL
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 11 at 9:00 PM
$NOTV Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.94 down -113.64% YoY • Reported revenue of $117.65M down -5.37% YoY • Inotiv's fiscal 2026 annual operating plan forecasts noncompliance with financial covenants, and existing cash is insufficient to fund operations for the next 12 months without a liquidity-enhancing transaction.
0 · Reply
Imadovitch
Imadovitch May. 9 at 7:03 PM
$NOTV When will the financial results for the second quarter be released?
0 · Reply
BillionerOfKing
BillionerOfKing May. 5 at 4:19 AM
$NOTV Current Stock Price: $0.30 Contracts to trade: $2.5 NOTV May 15 2026 Call Entry: $0.05 Exit: $0.08 ROI: 76% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
11thestate
11thestate May. 4 at 3:15 PM
Imagine buying $NOTV at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $NOTV investors out there, we’ve got some important news for you: A $8.75 million recovery fund is officially open to shareholders who bought between September 21, 2021 and May 20, 2022. The Settlement is currently accepting "Late-but-Valid" claims. This recovery fund was established after claims that Inotiv misled investors over the company’s acquisition of Envigo and failed to disclose related regulatory and operational risks. Even though the official deadline has passed, the court is still accepting late submissions. Claim your share here: https://11th.com/cases/inotiv-investor-settlement
0 · Reply
Mimarcano
Mimarcano May. 4 at 1:04 PM
$NOTV 👀👀
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 1 at 11:25 PM
$NOTV RSI: 58.82, MACD: -0.0018 Vol: 0.04, MA20: 0.28, MA50: 0.31 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RocketThief
RocketThief May. 1 at 4:55 PM
$NOTV how cute, penny pumper is getting excited because his YOLO play is up a few pennies 🤣. Don’t let this guy suck you in to his losing bet
0 · Reply
Sam201
Sam201 May. 1 at 2:52 PM
$NOTV someone help this retard! 😂🤣
0 · Reply